Mylan, a global pharmaceutical company, was hit with a class-action racketeering lawsuit April 3. The company is charged with intentionally setting up an illegal scheme in which they’ve drastically increased the price of their EpiPen over the past ten years. Roughly a decade ago, consumers were...